Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,066 | 889 | 99.7% |
| Education | $43.81 | 6 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,120 | 201 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,445 | 67 | $0 (2024) |
| Amgen Inc. | $981.03 | 56 | $0 (2024) |
| ABBVIE INC. | $752.55 | 57 | $0 (2024) |
| Lilly USA, LLC | $664.00 | 39 | $0 (2022) |
| PFIZER INC. | $594.59 | 54 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $539.86 | 36 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $534.34 | 35 | $0 (2024) |
| Allergan, Inc. | $499.16 | 46 | $0 (2020) |
| Amarin Pharma Inc. | $493.62 | 28 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,330 | 88 | Novo Nordisk Inc ($272.05) |
| 2023 | $669.83 | 49 | Novo Nordisk Inc ($144.96) |
| 2022 | $1,407 | 89 | Novo Nordisk Inc ($612.89) |
| 2021 | $1,644 | 100 | AbbVie Inc. ($333.46) |
| 2020 | $2,486 | 181 | Novo Nordisk Inc ($503.49) |
| 2019 | $2,445 | 171 | Novo Nordisk Inc ($507.93) |
| 2018 | $2,432 | 120 | Novo Nordisk Inc ($540.22) |
| 2017 | $1,695 | 97 | AstraZeneca Pharmaceuticals LP ($284.60) |
All Payment Transactions
895 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Diabetes Care | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Hematology | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $5.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/15/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Hematology | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Cardio-renal | ||||||
| 11/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Endocrinology | ||||||
| 10/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: PAIN | ||||||
| 10/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Biological | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.07 | General |
| Category: Obesity | ||||||
| 10/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Oncology | ||||||
| 10/16/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/15/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 585 | 788 | $108,931 | $54,796 |
| 2022 | 9 | 534 | 762 | $95,358 | $48,272 |
| 2021 | 10 | 505 | 741 | $122,475 | $48,168 |
| 2020 | 14 | 756 | 1,091 | $187,425 | $56,635 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 141 | 141 | $21,855 | $16,811 | 76.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 213 | $43,954 | $15,320 | 34.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 165 | $24,531 | $9,606 | 39.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $5,415 | $5,307 | 98.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 24 | $6,456 | $3,091 | 47.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 28 | 28 | $2,296 | $2,014 | 87.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 33 | $1,188 | $940.50 | 79.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 40 | 80 | $1,200 | $754.39 | 62.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $684.00 | $541.50 | 79.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 34 | $1,224 | $340.56 | 27.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 26 | 32 | $128.00 | $70.40 | 55.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 234 | $45,017 | $17,720 | 39.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 124 | 124 | $19,220 | $15,561 | 81.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 91 | 153 | $20,655 | $8,867 | 42.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 37 | 37 | $3,034 | $2,536 | 83.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 42 | 42 | $1,512 | $1,151 | 76.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,091 | $1,097 | 35.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 41 | 91 | $1,365 | $865.05 | 63.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 37 | $1,332 | $400.99 | 30.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 22 | 33 | $132.00 | $73.07 | 55.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 165 | 280 | $64,254 | $22,269 | 34.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 116 | 189 | $28,807 | $10,907 | 37.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 80 | 80 | $18,877 | $10,117 | 53.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 13 | $3,836 | $1,717 | 44.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 26 | 26 | $2,213 | $1,684 | 76.1% |
About Tracy Jacobs
Tracy Jacobs is a Family Medicine healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2008. The National Provider Identifier (NPI) number assigned to this provider is 1245498989.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tracy Jacobs has received a total of $14,110 in payments from pharmaceutical and medical device companies, with $1,330 received in 2024. These payments were reported across 895 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($14,066).
As a Medicare-enrolled provider, Jacobs has provided services to 2,380 Medicare beneficiaries, totaling 3,382 services with total Medicare billing of $207,870. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Birmingham, AL
- Active Since 05/29/2008
- Last Updated 09/23/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1245498989
Products in Payments
- FARXIGA (Drug) $1,198
- Saxenda (Drug) $1,110
- Ozempic (Drug) $871.36
- JARDIANCE (Drug) $595.48
- Vascepa (Drug) $493.62
- UBRELVY (Drug) $438.75
- XIFAXAN (Drug) $423.02
- Livalo (Drug) $401.68
- VRAYLAR (Drug) $356.13
- Repatha (Biological) $341.87
- JANUVIA (Drug) $327.00
- Aimovig (Biological) $322.36
- LINZESS (Drug) $299.54
- TRELEGY ELLIPTA (Drug) $270.43
- Wegovy (Drug) $266.59
- NURTEC ODT (Drug) $252.57
- EMGALITY (Drug) $219.24
- Victoza (Drug) $214.22
- XARELTO (Drug) $206.55
- CHANTIX (Drug) $188.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Birmingham
Dr. Lashelle Barmore, D.o, D.O
Family Medicine — Payments: $484,700
Dr. Nova Law, M.d, M.D
Family Medicine — Payments: $162,847
Dr. Michael Vaughn, M.d, M.D
Family Medicine — Payments: $50,495
Dr. Christopher Carter, M.d, M.D
Family Medicine — Payments: $42,656
Dr. Terry Smith, M.d, M.D
Family Medicine — Payments: $23,057
Scott Weisberg, M.d, M.D
Family Medicine — Payments: $18,210